🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Studying samples of blood and tissue from smokers (closed to ent...
Status
Completed
Location
Providence Cancer Center
Start Date
2005-10
Trial ID
NCT00450281
Treatments Being Tested
RATIONALE: Studying samples of tumor tissue from patients with cancer in th...
Status
Completed
Location
Multiple Locations
Start Date
2012-03
Trial ID
NCT01553175
This phase II trial studies how well ipilimumab works in treating patients ...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2012-12-03
Trial ID
NCT01693783
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as floxuridine and dexamethason...
Status
Completed
Location
New York Weill Cornell Cancer Center at Cornell University
Start Date
2007-05-09
Trial ID
NCT00410956
The aims of this study are: * Characterisation of immunological effects of...
Status
Completed
Location
Sport- und Rehazentrum GbR
Start Date
2012-01
Trial ID
NCT01333930
Treatments Being Tested
Definition: Idiopathic CD4+ T lymphocytopenia (ICL) is an immune deficiency...
Status
Completed
Location
Cochin Hospital
Start Date
2013-09-10
Trial ID
NCT02113930
Treatments Being Tested
RATIONALE: Tests that measure certain changes in blood in patients at high ...
Status
Completed
Location
Multiple Locations
Start Date
2000-01
Trial ID
NCT00716911
This is an observational study to develop new hypothesis regarding the dyna...
Status
Completed
Location
University Hospital Basel, Switzerland
Start Date
2012-03
Trial ID
NCT02277964
This phase I/II trial studies the side effects and best dose of ipilimumab ...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2014-03-07
Trial ID
NCT01896999
Despite improvements in corneal transplantation, anti-angiogenic and anti-l...
Status
Completed
Location
Damien JOLLY
Start Date
2021-04-21
Trial ID
NCT05009407
Treatments Being Tested